Effects of miR-193a and sorafenib on hepatocellular carcinoma cells

BACKGROUND: Hepatocellular carcinoma (HCC) is a challenging malignancy of global importance, it is the third most common cause of cancer-related mortality worldwide. In the last years the multikinase inhibitor sorafenib has been used for advanced HCC, but some patients do not benefit from this thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvi, Alessandro, Conde, Isabel, Abeni, Edoardo, Arici, Bruna, Grossi, Ilaria, Specchia, Claudia, Portolani, Nazario, Barlati, Sergio, De Petro, Giuseppina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029516/
https://www.ncbi.nlm.nih.gov/pubmed/24330766
http://dx.doi.org/10.1186/1476-4598-12-162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029516/
https://www.ncbi.nlm.nih.gov/pubmed/24330766
http://dx.doi.org/10.1186/1476-4598-12-162

Ejemplares similares